The impact of membrane lipid composition on antimicrobial function of an α-helical peptide

Chemistry and Physics of Lipids

Volumn 151, Issue 2, 2008, Pages 92-102

  Dennison, Sarah R ^a   Morton, Leslie H G ^a   Harris, Frederick ^a   Phoenix, David A ^a  

^a UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

Author keywords

helical; Antimicrobial peptide; Bacterial membrane; Langmuir Blodgett; Lipid extract; Membrane lipid; Monolayer; Thermodynamic analysis

Indexed keywords

CARDIOLIPIN; LIPID; PEPTIDE; PHOSPHATIDYLGLYCEROL; PROTEIN VP1;

ALPHA HELIX; ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL MEMBRANE; COMPRESSION; ESCHERICHIA COLI; INFRARED SPECTROSCOPY; ISOTHERM; LANGMUIR BLODGETT FILM; LIPID COMPOSITION; LIPID VESICLE; MEMBRANE STABILIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; THERMODYNAMICS;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACILLUS SUBTILIS; ESCHERICHIA COLI; MEMBRANE LIPIDS; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PRESSURE; PROTEIN STRUCTURE, SECONDARY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PROPERTIES; THERMODYNAMICS;

BACILLUS SUBTILIS; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 38749122418     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2007.10.007     Document Type: Article

References (53)

1. Alminana N., Alsina M.A., Ortiz A., and Reig F. Comparative physicochemical study of SIKVAV peptide and its retro and retro-enantio analogues. Colloids Surf. A Physicochem. Eng. Asp. 249 (2004) 19-24
2. Ambroggio E.E., Separovic F., Bowie J., and Fidelio G.D. Surface behaviour and peptide-lipid interactions of the antibiotic peptides, Maculatin and Citropin. Biochim. Biophys. Acta 1664 (2004) 31-37
3. Ambroggio E.E., Separovic F., Bowie J.H., Fidelio G.D., and Bagatolli L.A. Direct visualization of membrane leakage induced by the antibiotic peptides: maculatin, citropin, and aurein. Biophys. J. 89 (2005) 1874-1881
4. Apponyi M.A., Pukala T.L., Brinkworth C.S., Maselli V.M., Bowie J.H., Tyler M.J., Booker G.W., Wallace J.C., Carver J.A., Separovic F., Doyle J., and Llewellyn L.E. Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance. Peptides 25 (2004) 1035-1054
5. Balla M.S., Bowie J.H., and Separovic F. Solid-state NMR study of antimicrobial peptides from Australian frogs in phospholipid membranes. Eur. Biophys. J. 33 (2004) 109-116
6. Bechinger B., and Lohner K. Detergent-like actions of linear amphipathic cationic antimicrobial peptides. Biochim. Biophys. Acta 1758 (2006) 1529-1539
7. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Med. Sci. 37 (1959) 911-917
8. Blume A. A comparative study of the phase transitions of phospholipid bilayers and monolayers. Biochim. Biophys. Acta 557 (1979) 32-44
9. Boland M.P., and Separovic F. Membrane interactions of antimicrobial peptides from Australian tree frogs. Biochim. Biophys. Acta 1758 (2006) 1178-1183
10. Brandenburg K., Kusumoto S., and Seydel U. Conformational studies of synthetic lipid A analogues and partial structures by infrared spectroscopy. Biochim. Biophys. Acta 1329 (1997) 183-201
11. Brandenburg K., Harris F., Dennison S., Seydel U., and Phoenix D. Domain V of m-calpain shows the potential to form an oblique-orientated alpha-helix, which may modulate the enzyme's activity via interactions with anionic lipid. Eur. J. Biochem. 269 (2002) 5414-5422
12. Brasseur R. Tilted peptides: a motif for membrane destabilization (hypothesis). Mol. Membr. Biol. 17 (2000) 31-40
13. Brogden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat. Rev. Microbiol. 3 (2005) 238-250
14. Bulet P., and Stocklin R. Insect antimicrobial peptides: Structures, properties and gene regulation. Prot. Pept. Lett. 12 (2005) 3-11
15. Castro M.S., Cilli E.M., and Fontes W. Combinatorial synthesis and directed evolution applied to the production of alpha-helix forming antimicrobial peptides analogues. Curr. Protein Pept. Sci. 7 (2006) 473-478
16. Chan C., Burrows L.L., and Deber C.M. Helix induction in antimicrobial peptides by alginate in biofilms. J. Biol. Chem. 279 (2004) 38749-38754
17. Curtin J., and Cormican M. Measuring antimicrobial activity against biofilm bacteria. Rev. Environ. Sci. Biotechnol. 2 (2003) 1569-1705
18. Davies J.T., and Rideal E.K. Interfacial Phenomena. 2nd ed. (1963), Academic Press, New York
19. del Pozo J.L., and Patel R. The challenge of treating biofilm-associated bacterial infection. Clin. Pharmacol. Ther. 82 (2007) 204-209
20. Demel R.A. Monolayers-description of use and interaction. Methods Enzymol. 32 (1974) 539-544
21. Dennison S.R., Dante S., Hauβ T., Brandenburg K., Harris F., and Phoenix D.A. Investigations into the membrane interactions of m-calpain domain V. Biophys. J. 88 (2005) 3008-3017
22. Dennison S.R., Harris F., and Phoenix D.A. Are oblique orientated alpha-helices used by antimicrobial peptides for membrane invasion?. Protein Pept. Lett. 12 (2005) 27-29
23. Dennison S.R., Whittaker M., Harris F., and Phoenix D.A. Anticancer alpha-helical peptides and structure/function relationships underpinning their interactions with tumour cell membranes. Curr. Protein Pept. Sci. 7 (2006) 487-499
24. Devine D.A., and Hancock R.E. Cationic peptides: distribution and mechanisms of resistance. Curr. Pharm. Des. 8 (2002) 703-714
25. Durr U.H.N., Sudheendra U.S., and Ramamoorthy A. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim. Biophys. Acta 1758 (2006) 1408-1425
26. Eisenberg D., Weiss R.M., and Terwilliger T.C. The helical hydrophobic moment: a measure of the amphiphilicity of a helix. Nature 299 (1982) 371-374
27. Giuliani A., Pirri G., and Nicoletto S.F. Antimicrobial peptides: an overview of a promising class of therapeutics. Cent. Eur. J. Biol. 2 (2007) 1-33
28. Hardy N.J., Richardson T.H., and Grunfeld F. Minimising monolayer collapse on Langmuir troughs. Colloids Surf. A Physicochem. Eng. Asp. 284/285 (2006) 202-206
29. Harris F., Wallace J., and Phoenix D.A. Use of hydrophobic moment plot methodology to aid the identification of oblique orientated alpha-helices. Mol. Membr. Biol. 17 (2000) 201-207
30. Henzler-Wildman K.A., Martinez G.V., Brown M.F., and Ramamoorthy A. Perturbation of the hydrophobic core of lipid bilayers by the human antimicrobial peptide LL-37. Biochemistry 43 (2004) 8459-8469
31. Jenssen H., Hamill P., and Hancock R.E.W. Peptide antimicrobial agents. Clin. Microbiol. Rev. 19 (2006) 491-511
32. Keller R.C., Killian J.A., and de Kruijff B. Anionic phospholipids are essential for alpha-helix formation of the signal peptide of prePhoE upon interaction with phospholipid vesicles. Biochemistry 31 (1992) 1672-1677
33. Kuo H.H., Chan C., Burrows L.L., and Deber C.M. Hydrophobic interactions in complexes of antimicrobial peptides with bacterial polysaccharides. Chem. Biol. Drug Des. 69 (2007) 405-412
34. Lohner K., and Prenner E.J. Differential scanning calorimetry and X-ray diffraction studies of the specificity of the interaction of antimicrobial peptides with membrane-mimetic systems. Biochim. Biophys. Acta 1462 (1999) 141-156
35. Marcotte I., Wegener K.L., Lam Y.H., Chia B.C., de Planque M.R., Bowie J.H., Auger M., and Separovic F. Interaction of antimicrobial peptides from Australian amphibians with lipid membranes. Chem. Phys. Lipids 122 (2003) 107-120
36. Marr A.K., Gooderham W.J., and Hancock R.E.W. Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr. Opin. Pharmacol. 6 (2006) 468-472
37. Marshall S.H., and Arenas G. Antimicrobial peptides: a natural alternative to chemical antibiotics and a potential for applied biotechnology. Electron. J. Biotechnol. 6 (2003) 1-13
38. Mookherjee N., and Hancock R.E.W. Cationic host defence peptides: Innate immune regulatory peptides as a novel approach for treating infections. Cell. Mol. Life Sci. 64 (2007) 922-933
39. Nizet V. Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets. J. Allergy Clin. Immunol. 120 (2007) 13-22
40. Quickenden T.I., and Tan G.K. Random packing in two dimensions and the structure of monolayers. J. Colloid Interface Sci. 48 (1974) 382-393
41. Rahman M., Lins L., Thomas-Soumarmon A., and Brasseur R. Are amphipathic asymmetric peptides ubiquitous structures for membrane destabilisation?. J. Mol. Model 3 (1997) 203-215
42. Ramamoorthy A., Thennarasu S., Lee D.K., Tan A., and Maloy L. Solid-state NMR investigation of the membrane-disrupting mechanism of antimicrobial peptides MSI-78 and MSI-594 derived from magainin 2 and melittin. Biophys. J. 91 (2006) 206-216
43. Rodriguez-Martinez J.M., and Pascual A. Antimicrobial resistance in bacterial biofilms. Rev. Med. Microbiol. 17 (2006) 65-75
44. Ronzon F., Desbat B., Chauvet J.-P., and Roux B. Penetration of a GPI-anchored protein into phospholipid monolayers spread at the air/water interface. Colloids Surf. B Biointerfaces 23 (2002) 365-373
45. Sato H., and Feix J.B. Peptide-membrane interactions and mechanisms of membrane destruction by amphipathic alpha-helical antimicrobial peptides. Biochim. Biophys. Acta 1758 (2006) 1245-1256
46. Seelig A. Local anesthetics and pressure: a comparison of dibucaine binding to lipid monolayers and bilayers. Biochim. Biophys. Acta 899 (1987) 196-204
47. 2): II. Miscibility in lipid monolayers. J. Colloid Interface Sci. 244 (2001) 87-96
48. Tamang D.G., and Saier M.H. The cecropin superfamily of toxic peptides. J. Mol. Microbiol. Biotechnol. 11 (2006) 94-103
49. Thomas A., and Brasseur R. Tilted peptides: the history. Curr. Protein Pept. Sci. 7 (2006) 523-527
50. Todd J. Introduction to the Constructive Theory of Functions (1963), Academic Press, New York
51. Zaiou M. Multifunctional antimicrobial peptides: therapeutic targets in several human diseases. J. Mol. Med. 85 (2007) 317-329
52. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415 (2002) 389-395
53. Zelezetsky I., and Tossi A. Alpha-helical antimicrobial peptides-using a sequence template to guide structure-activity relationship studies. Biochim. Biophys. Acta 1758 (2006) 1436-1449